Email updates

Keep up to date with the latest news and content from Virology Journal and BioMed Central.

Open Access Research

Development and validation of an ELISA using a protein encoded by ORF2 antigenic domain of porcine circovirus type 2

Shi-Qi Sun, Hui-Chen Guo*, De-Hui Sun, Shuang-Hui Yin, You-Jun Shang, Xue-Peng Cai and Xiang-Tao Liu*

Author Affiliations

State Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Animal Virology of Ministry of Agriculture, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Xujiaping 1, Lanzhou, 730046, The People's Republic of China

For all author emails, please log on.

Virology Journal 2010, 7:274  doi:10.1186/1743-422X-7-274

The electronic version of this article is the complete one and can be found online at: http://www.virologyj.com/content/7/1/274


Received:22 July 2010
Accepted:19 October 2010
Published:19 October 2010

© 2010 Sun et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

The capsid protein (ORF2) is a major structural protein of porcine circovirus type 2 (PCV2). A simple and reliable diagnostic method based on ORF2 protein immunoreactivity would serve as a valuable diagnostic method for detecting serum antibodies to PCV2 and monitoring PCV infection. Here, we reported an indirect enzyme-linked immunosorbent assay (I-ELISA) by using an antigenic domain (113-147AA) of ORF2-encoded antigen, expressed in E. coli, for diagnosis of PCV infection.

Results

The ELISA was performed on 288 serum samples collected from different porcine herds and compared with an indirect immunofluorescent assay (IFA). In total, 262 of 288 samples were positive as indicated by both I-ELISA and IFA. The specificity and sensitivity of I-ELISA were 87.7% and 93.57%.

Conclusions

This ELISA is suitable for detection and discrimination of PCV2 infection in both SPF and farm antisera.

Background

Porcine circovirus (PCV) is a member of circoviridae. It is a small non-enveloped DNA virus with a circular single-stranded genome [1]. Genomic analysis revealed that there are two distinct genotypes of PCV [2-5]. The PCV1 was identified as a persistent non-cytopathic contaminant of the porcine kidney cell line PK-15 [6,7]. In contrast, PCV2 is considered the primary causative agent for post weaning multisystemic wasting syndrome (PMWS) [8-11]. The genome DNA of both PCV1 and PCV2 consist of several major open reading frames; of these, ORF1, ORF2, and ORF3 have been studied. The ORF1 encodes a replication-associated protein of 35.7 kDa [12], while ORF2 encodes a major immunogenic capsid protein of approximately 30 kDa [13] and ORF3 plays a major role in PCV2-induced apoptosis [14].

Post weaning multisystemic wasting syndrome is a disease of growing pigs that causes low morbidity but high case mortality. The disease is characterized by progressive weight loss, respiratory and digestive disorders, lymphohistiocytics, and lymphoid depletion [8,15,16]. Most regions of the world have reported PMWS cases [5,9,17-23], and it is currently considered an important swine disease with potentially serious economic impacts for the global swine industry.

As a control measure, specific serologic detection is essential. To date, immunoperoxidase monolayer assay (IPMA)[24] and indirect immunofluorescent assay (IFA)[25] are the most widely used diagnostic methods for detecting PCV infection. However, these methods are labor-intensive and time consuming, and carry the risk of virus contamination. These techniques require experienced technicians who can judge the staining reactions accurately. In contrast, enzyme linked immunosorbent assay (ELISA) can decrease the potential bias that may occur with IFA and IPMA and is amenable to automation, so it is suitable for large-scale diagnostics.

Recently, several ELISAs for detecting PCV infection have been developed. Some have been based on cell-culture-propagated PCV2 and specific PCV2 monoclonal antibodies [26]. These assays are more expensive, of greater technical difficulty than ELISA based on recombinant major capsid protein [13]. Recent studied have adopted ELISA based on recombinant major capsid protein expressed in recombinant baculovirus-infected cells [27,28]; however this is still not optimal because it is more difficult to isolate sufficient proteins from this expression system than from bacterial expression systems.

Several antigenic epitopes of the capsid protein were demonstrated at amino acid residues 65-87, 113-147, 157-183, and 193-207. The 113-147 epitope proved to be the immunorelevant epitope for virus type discrimination [29]. Truong et al. [30] developed a peptide-ELISA using a chemically synthesized epitope of PCV2 ORF2. Here, we describe a PCV2 ORF2 immunorelevant epitope (ORF2-E) isolated from a bacterial expression system and used as the coating antigen for ELISA. The aim was to establish an ELISA diagnosis method to detect anti-PCV2 antibody in infected swine.

Results

Cloning and sequencing of PCV2 ORF2

There are five dominant immunoreactive areas on PCV-encoded proteins, one located on ORF1 and four on ORF2 [29]. However, only one antigenic domain (113-147) of ORF2 protein was suitable for an ELISA to detect swine PCV2 infection. We cloned the 102 bp nucleotide encoding the 113-147 peptide of ORF2 protein (Figure 1).

thumbnailFigure 1. (A) The map of dominant immunoreactive areas of ORF2. The amino acid residues of each area are identified. (B) The ORF2 fragment that spans from amino acid 113 to 147 was amplified with a pair of ORF2 primers (Lane 1). The entire ORF2 fragment was used as a positive control (Lane 2). The DNA marker is a 500 bp DNA ladder.

Analysis of recombinant protein

We constructed an expression vector, pGEX-ORF2-E, which allowed the ORF2 antigenic domain to be expressed as a GST-tagged fusion protein (GST-ORF2-E) for efficient purification. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western-blotting were used to confirm expression of the recombinant protein. The presence of the fusion protein in the bacterial cell fractions before induction and after induction was analyzed. There was a band of about 29 kDa on the SDS-PAGE gel (Figure 2), both from the sonicated pellet and a more intense band from the supernatant remaining from centrifugation of the sonicated cell suspension (Figure 2), indicating that most of GST-ORF2-E protein was soluble. Western-blotting using the anti-GST monoclonal antibody further confirmed that the fusion protein GST-ORF2-E was expressed correctly in bacterium.

thumbnailFigure 2. The expression of GST-ORF2-E protein was analyzed by SDS-PAGE (A) and Western-blotting (B) with an anti-GST monoclonal antibody. Lane 1, BL21 cell lysate before induction of IPTG; Lane 2, BL21 cell lysate after induction of IPTG; Lane 3, Supernatant of cell lysate after sonication and centrifugation; Lane 4, Pellet of cell lysate after sonication and centrifugation, There was a clear band of 29 kDa (arrow) after induction. The protein marker includes 8 bands at 175, 83, 62, 47.5, 32.5, 25, 16.5, and 6.5 kDa.

To test the antigenicity of GST-ORF2-E, we used the PCV2 swine serum as a primary antibody in western-blotting (Figure 3 and Figure 4). There was a strong signal on the NC membrane against positive serum but no signal against negative serum. Similarly, the expected 29 kDa band appeared on the western-blotting membrane using an anti-GST monoclonal antibody and porcine serum.

thumbnailFigure 3. Western-blotting analysis of the expressed recombinant GST-ORF2-E protein with porcine serum (above) was confirmed by IFA (below). A clear band with the expected molecular weight appeared on the NC membrane after incubation with two positive porcine serum samples (A, B), but no equal band appeared when incubated in two samples of negative porcine serum (C, D). Lane 1, BL21 cell lysate before induction of IPTG; Lane 2, BL21 cell lysate after induction of IPTG; Lane 3, Supernatant of cell lysate after sonication and centrifugation; Lane 4, Pellet of cell lysate after sonication and centrifugation; Protein marker includes 8 bands of 175, 83, 62, 47.5, 32.5, 25, 16.5, and 6.5 kDa.

thumbnailFigure 4. Confirmation of purified GST-ORF2-E protein by SDS-PAGE and western-blotting. (A) SDS-PAGE of purified protein after elution. Lane 1: The first elution; Lane 2: The second elution; Lane 3: The third elution. (B) Western-blotting with GST monoclonal antibody. Lane 1, BL21 cell lysate before induction of IPTG; Lane 2, BL21 cell lysate after induction of IPTG; Lane 3, Purified protein. (C) and (D) are results of western-blotting using positive (C) or negative (D) porcine serum as the primary antibody. Protein marker includes 8 bands at 175, 83, 62, 47.5, 32.5, 25, 16.5, and 6.5 kDa.

Evaluation of GST-ORF2-E proteins ELISA

To coat plates for ELISA, the optimum concentration of antigen was determined by checkerboard titration. A final protein concentration of 0.5 μg/mL was determined. Using this optimal concentration of coating antigen, the optimal dilution of the HRP-conjugated anti-pig IgG was obtained at 1:3000 by checkerboard titration. A field serum dilution of 1 to 100 was selected as an optimum dilution for assays. Phosphate buffered saline containing 0.1% Tween-20 and 5% (w/v) non-fat dry milk as the blocking buffer, and PBS containing 0.1% Tween-20 and 1% (w/v) non-fat dry milk as the dilution buffer, were determined to have a good positive/negative (P/N) ratio.

To determine whether the GST tag interfered with the GST-ORF2-E ELISA, we coated plates with either purified GST protein or GST-ORF2-E and tested the optical density (OD) after treatment with 10 samples of positive and 10 samples of negative sera (Figure 5). The statistical analysis (two-sample paired T-test) showed that average OD of positive sera tested by GST-ORF2-E was significantly different than that tested on GST alone (P < 0.01) and the average OD of negative sera tested by GST-ORF2-E was significant different than that tested on GST alone (0.01 <P < 0.05). Moreover, the average OD of positive sera tested on GST alone was not significant different from that of negative sera tested on GST alone (P > 0.05).

thumbnailFigure 5. ELISA using GST as a reference for evaluation of non-specific binding. Twenty serum samples including 10 positive sera (A) and 10 negative sera (B) were used. Each serum sample was run in quadruplicate, two on GST-ORF2-E antigen and two on GST antigen wells. Positive and negative control sera were induced in every plate.

Confirmation of negative-positive cutoff

A cutoff point for each assay was determined so that DSN and DSP were maximized while the sum of false negative and false positive results was minimized. The OD at 490 nm for negative sera ranged from 0.068 to 0.209. The averaged OD of 25 negative pig sera in the ELISA was 0.12466, yielding a suitable cut-off OD value of 0.224313 (mean + 3SD) in this assay and indicated that 99% of the negative sera have OD values below 0.22. The positive threshold was set at 0.22. Based on this criterion, all 25 positive sera have OD values above 0.22.

Evaluation of assay repeatability

The repeatability test was done by comparing OD ratios of triplicate results from each field serum sample tested in the same plate (intra-assay repeatability) or in different plates at different times (inter-assay repeatability). The intra-assay CV of 10 positive serum samples ranged from 0.12% to 14.87%, with a median value of 2.34%, while those of negative serum samples ranged from 0.46% to 6.45%, with a median value of 2.17%. The inter-assay CV for positive serum samples was between 11.26% and 37.04%, with a median value of 19.03%, whereas the CV for negative serum samples was between 10.16% and 38.26%, with a median value of 31.74%. These data showed that the assay was repeatable and yielded a low and acceptable variation.

Evaluation of assay specificity and sensitivity

The PCV2 GST-ORF2-E ELISA results were obtained from 288 serum samples. The results for these serum samples were compared with those obtained by the IFA reference method (serum sample diluted 1:50). The diagnostic sensitivity and specificity of the ELISA test were determined using the formulae given in the methods. The result demonstrated that the sensitivity and specificity of the ELISA test were higher than IFA (Table 1). The negative and positive serum determinations were 8 and 280 by IFA and 25 and 263 by ELISA. The specificity relative to IFA was 87.7% and sensitivity was 93.57% (the agreement rate was 93.4%). Cross-reaction was analyzed by testing the reactivity of antibodies against other porcine viruses with the antigenic domain antigen. As showed in Table 2, there was no cross-reactivity between the PCV2 113-147 domain of ORF2 and antibodies against other porcine viruses, proving that the domain antigen was specific for antibody to PCV2.

Table 1. Comparison between the IFA and ELISA for field sera

Table 2. Cross-reaction analysis of the domain based ELISA to antisera against other swine viruses

Evaluation of correlation between ELISA and IFA

The correlation between IFA titer and OD ratio was determined by plotting endpoint IFA titers of 16 serum samples with different levels of antibodies to PCV2 against OD ratios of the corresponding serum (Figure 6). The results indicated that the linear relationships between log10 titer of IFA and OD ratio obtained from GST-ORF2-E ELISA (spearman's rank correlation = 0.9665; P < 0.0001) were similar, which means the relationships between IFA titers and OD ratios of GST-ORF2-E are linear (the regression equation was: IFA titer = 1.21339 × A490 + 3.41189, r2 = 0.7897, P < 0.001). In conclusion, OD ratio obtained from GST-ORF2-E ELISA could be used to predict IFA titer.

thumbnailFigure 6. Scatter plots of log10 IFA titers of 16 serum samples against OD ratios of the corresponding serum obtained from GST-ORF2-E ELISA.

Discussion

The ORF1 and ORF2 of both PCV types show about 60 to 80 percent sequence identity at the amino acid level, and this homology was shown to be relativity well conserved between different PCV isolates [4,5,12]. This indicates that there will be significant antigenic cross-reactivity between viral products of the PCV genotypes. Even though currently available methods, such as indirect immunoperoxidase and immunofluorescence assays, are widely used for the serological diagnosis of PCV2 infection, these assays are labor intensive and time consuming. Furthermore, cross reactions between PV1 and PV2 could lead to false-positives. It was previously shown that there is common immunoreactivity epitope on the ORF1-encoded protein, but there was no cross-reactivity between the ORF2-encoded proteins of PCV1 and PCV2 [9,25,29]. Therefore, in order to develop a PCV2-specific indirect ELISA diagnosis assay, we first focused on the expression of whole ORF2 in E. coli that bares an arginine-enriched nuclear localization signal. Liu et al. [31] previously reported that the whole ORF2 protein was not expressed successfully in E. coli., so we designed a vector containing only the immunorelevant epitope [29] of ORF2 protein in frame with a GST tag to efficiently isolate protein from bacteria (about 20 mg/L cells). In addition, the GST tag increased the solubility of target proteins, and does not generally interfere with biological activity. The recombinant GST-ORF2-E protein reacted strongly with PCV2-infected swine serum, demonstrating its biological activity and also suggesting possible use in diagnostic assays. The result in this study proved that affinity-purified GST-ORF2-E protein can be employed to improve the sensitivity and specificity of the I-ELISA.

To determine whether the GST tag in recombinant ORF2 protein enhanced the OD value to produce false-positive results, we compared plates coated with GST protein alone with plates coated with GST-ORF2-E protein. According to average OD value from positive or negative serum, GST tag in recombinant GST-ORF2-E was not specific to swine serum, demonstrating that GST-ORF2-E can be used as a coating antigen for the detection of PCV-2 antibodies by indirect ELISA.

The newly developed ELISA showed repeatability for negative sera as indicted by the low variability among replicates from the same sample. There was smaller differences between intra-assay trials than inter-assay trials, however, suggesting that optimization is not complete, especially the stability of antigen. However, the CV for positive and negative serum samples in two assays indicated that the intra-assay variability of this GST-ORF2-E ELISA was acceptable.

The OD ratio of the GST-ORF2-E ELISA showed significant agreement with the antibody rates of IFA for field sera, so the ELISA can be used for direct comparison of antibody concentrations in field samples and could be of particular importance for dynamic studies of PCV. However, several IFA-positive sera were classified as negative by GST-ORF2-E ELISA. This may be due to antibody binding affinity and stability of the antigen-antibody complex in the short peptide relative to binding onto the whole virus. Indeed, the source of antigen for IFA was fixed cells, while the ELISA antigens were soluble. So, as expected, both types of antigens contain shared and distinct epitopes which will be recognized by different antibodies. Another reason may be that the PCV1 contamination maybe results in significant false-positive in IFA. Moreover, as Nawagitgul et al. reported [13], evaluating a newly developed assay by comparison with a widely used assay is not an absolute standard of comparison. In this study, sera with an IFA titer of 1:50 or more were defined as positive, while for the ELISA, sera with 1:100 or more were considered positive. Therefore, it is possible that the IFA might result in more false positives due to the low dilution of serum samples. However, the GST-ORF2-E ELISA is specific for PCV2, which is related to the PCV2 specific antigenic epitope in ELISA. This result also confirmed that the GST-ORF2-E ELISA can be used to selectively detect the anti-PCV2 antibody in infected swine.

Conclusions

The present study clearly shows that detection of PCV2 antibodies by I-ELISA using ORF2-E as an antigen is specific, sensitive, inexpensive, rapid, and easy to perform. Moreover, the method can distinguish PCV2-infected pig sera from PCV1-infected serum. Consequently, the I-ELISA described in this report may be a particularly valuable test for the routine diagnosis of PCV2 infection in pigs.

Methods

Cell virus and sera

The permanent PK15 cell line, which was free of PCV, was maintained in minimal essential medium (MEM) supplemented with 10% fetal bovine serum (FBS) (Gibco BRL). The wild-type PCV2 virus used in the study was originally isolated from a kidney tissue sample of a pig with naturally occurring PMWS. A total of 288 field serum samples were collected from different region of Gansu province, China. Positive sera against classic swine fever virus (CSFV), porcine parvovirus (PPV), and porcine reproductive and respiratory syndrome virus (PRRSV) from SPF pigs were purchased from the Chinese Institute of Veterinary Drug Control.

Cloning and sequencing of PCV2 capsid protein antigenic domain

The PCV2 genome was used as template for amplification of the virus capsid protein gene by polymerase chain reaction (PCR). The PCR was performed using a pair of primers (ORF2-EF:5'-GC GGA TCC CAG GGT GAC AGG GGA GTG GGC T-3' and ORF2-ER:5'-GC CTC GAG TTA GCG GGA GGA GTA GTT TAC A-3'). The thermocycle condition was an initial denaturing at 94°C for 2 min, followed by 30 cycles of 94°C for 20 sec, 60°C for 20 sec, and 72°C for 30 sec. The elongation time was 8 min at 72°C. The PCR fragment was cloned between the BamHI and XhoI sites of the pGEX-4T-1 vector (Amersham-Pharmacia Biotech) and in frame with the glutathione S-transferase (GST) sequence. The nucleotide sequence of the construct was verified by DNA sequencing.

Expression and purification of ORF2-E fusion proteins in E. coli

Recombinant GST-ORF2-E protein and GST protein were expressed in E. coli BL21. E. coli containing the expression plasmid were grown overnight at 37°C in LB medium with 100 μg/mL ampicillin. Cells were then diluted 1:100 and allowed to grow at 37°C to an optical density between 0.6 and 0.8 at 600 nm. Isopropylthio-β-D-galactoside (IPTG) was added to a final concentration of 0.1 mM. Following 3 h of growth, cells were harvested by centrifugation.

The GST-ORF2-E fusion protein was purified from the bacterial lysate by using a glutathione affinity column (Amersham-Pharmacia Biotech). Briefly, cell pellets were resuspended in ice-cold PBS and sonicated for 10 min (power 3, on 30 sec; off 30 sec). After the sonicated solution was centrifuged, the supernatant was then transferred to a 50% slurry of Glutathione Sepharose 4B equilibrated with PBS. Followed incubation with gentle agitation at room temperature for 30 min, the matrix was transferred to a disposable Column. The matrix was washed with PBS and the fusion protein eluted by glutathione elution buffer. The eluate was collected and GST fusion protein was analyzed by SDS-PAGE and Western-blotting.

Protein expression analysis

Proteins were separated by SDS-PAGE on 12% acrylamide gels using a discontinuous buffer system. For Western blotting, proteins were transferred to nitrocellulose membranes (GIBCO BRL) in transfer buffer (20 mM Tris-HCl, 190 mM glycine, 20% methanol, pH 8.3) using a Mini Trans-blot transfer system (Bio-Rad) at 100 V for 1 h. The membranes were blocked with 5% nonfat dried milk in TTBS (Tris-buffered saline containing 0.05% Tween-20) at room temperature for 1 h and then incubated with anti-GST monoclonal antibody (Dako, 1:500) or swine sera (1:200) at room temperature for 1 h. After three washes in TTBS, the membranes were incubated with 1:2000 peroxidase-conjugated anti-mouse or anti-swine antibody (Dako) at room temperature for another 1 h. After washing with TTBS, the reacted patterns were visualized with DAB (3, 3'-Diaminobenzidine) substrate (Sigma).

IFA

To prepare plates for IFA, the PK-15 cells were split one day before infection. A 100 μL suspension of freshly trypsinized PK-15 cells at a concentration of 5×104 cells/mL was transferred into a 96-well plate. The PCV2 at a multiplicity of infection (MOI) of 0.1 were inoculated into rows 1, 3, 5 and 7 of the 96-well plate. Mock-infected PK-15 cells were prepared similarly to PCV2-infected cells and seeded in alternate rows. Cells were treated with 300 mM D-glucosamine in Hank's buffer at 37°C for 20-30 min at 4-6 hours post-infected (hpi) and then cultured in a humidified incubator aerated with 5% CO2 for 72 h at 37°C. Cells were fixed with 4% PFA (polyformaldehyde) in PBS at room temperature for 30 min and washed with PBST (PBS pH 7.4 containing 0.1% Tween-20). The cells were then incubated for 10 min at room temperature with 0.1% Triton X-100 in PBS, followed by incubation for a further 1 h at 37°C with pig serum diluted 50 times in PBST containing 5% FBS. After three washes with PBST, cells were stained for 1 h at 37°C with FITC-conjugated rabbit anti-swine IgG (Dako) diluted 100 times in PBST containing 5% FBS. After washing, plates were examined using fluorescence microscopy.

ELISA procedure

Ninety-six microtiter plates (Nunc Maxisorp) were coated with 100 μL GST-ORF2-E antigen in 0.05 M bicarbonate buffer (pH 9.6) and incubated overnight. After two washes in PBST, the plates were blocked with 100 μL PBST containing 5% non-fat dry milk for 1 h at 37°C. After washing, a diluted pig serum with PBST containing 1% non-fat dry milk was added, and plates were again incubated for 1 h at 37°C. After rinsing three times with PBST, 100 μL diluted rabbit anti-swine IgG conjugated with peroxidase (Dako) in the PBST containing 1% non-fat dry milk was added, and then incubated at 37°C for another 1 h. The plates were then washed three times, and the colorimetric reaction was developed using 50 μL substrate solution (FAST ο-phenylenediamine dihydrochloride, Sigma) for 15 min at 37°C. Color development was stopped with 50 μL of 2N H2SO4, and optical density (OD) was read at 490 nm.

Confirmation of negative-positive cutoff

The negative-positive cutoff value was set by the average OD ratio of 25 field negative sera and 25 positive sera by GST-ORF2-E ELISA. A negative-positive threshold for each assay was calculated using the Microsoft Excel spreadsheet.

Evaluation of assay repeatability

Ten negative serum samples and 10 positive serum samples were selected for the repeatability test. For intra-assay (within-plate) repeatability, three replicates of the same serum sample were performed in the same plate. For inter-assay (between-run) repeatability, three replicates of each sample were run in different plates on different occasions. Mean OD ratio; standard deviation (SD), and coefficient of variation (CV) of three replicates of each test were calculated.

Evaluation of assay specificity and sensitivity

The diagnostic sensitivity (DSn) and specificity (DSp) of the ELISA test were determined using the following formulae: DSn = TP/(TP+FN)×100 (where TP is the true positive and FN is the false negative) and DSp = TN/(TP+TN) ×100 (where TN is true negative and FP is false positive). The accuracy is (TP+TN)/total number of serum samples tested ×100 [13].

Evaluation of correlation between ELISA and IFA

ELISA values (OD ratios) obtained from sera taken from the sixteen PCV2-infected pigs were compared with antibody titers determined by IFA on PCV2-infected cells. The IFA was performed on serial dilutions of the corresponding sera from 1:50 to 1:51,200. A correlation between the IFA titer and the OD ratio was determined by the Spearman's correlation coefficient.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

SQS conceived and designed the study, organized protocol developments, interpreted of data and wrote the manuscript. HCG took part in development of ELISA and IFA protocols, carried out ELISA and IFA, contributed to the interpretation of the findings and revised the manuscript. DHS, SHY and YJS carried out PCR and protein expression and purification. XTL and XPC additionally contributed to the study design, contributed to conception, interpretation of data and revision of the manuscript. All authors' have read and approved the final manuscript.

Acknowledgements

This study was funded in part with grants from the ministry of science and technology of China (No.2008FY130100) and science and from technology committee of Gansu(No.1002NKDA037).

References

  1. Tischer I, Gelderblom H, Vettermann W, Koch MA: A very small porcine virus with circular single-stranded DNA.

    Nature 1982, 295:64-66. PubMed Abstract | Publisher Full Text OpenURL

  2. Hamel AL, Lin LL, Nayar GP: Nucleotide sequence of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs.

    The Journal of Virology 1998, 72:5262-5267. OpenURL

  3. Meehan BM, Creelan JL, McNulty MS, Todd D: Sequence of porcine cirovirus DNA:affinities with plant circoviruses.

    Journal of General Virology 1997, 78:221-227. PubMed Abstract | Publisher Full Text OpenURL

  4. Meehan BM, McNeilly F, Todd D, Kennedy S, Jewhurst VA, Ellis JA, Hassard LE, Clark EG, Haines DM, Allan GM: Characterization of novel circovirus DNAs associated with wasting syndrome in pigs.

    Journal of General Virology 1998, 79:2171-2179. PubMed Abstract | Publisher Full Text OpenURL

  5. Morozov I, Sirinarumitr T, Sorden SD, Halbur PG, Morgan MK, Yoon KJ, Paul PS: Detection of a novel strain of porcine circovirus in pigs with postweaning multisystemic wasting syndrome.

    Journal of Clinical Microbiology 1998, 36:2535-2541. PubMed Abstract | PubMed Central Full Text OpenURL

  6. Allan GM, McNeilly F, Cassidy JP, Reilly GA, Adair B, Ellis WA, McNulty MS: Pathogenesis of porcine circovirus; experimental infections of colostrum deprived piglets and examination of pig foetal material.

    Veterinary Microbiology 1995, 44:49-64. PubMed Abstract | Publisher Full Text OpenURL

  7. Tischer I, Mields W, Wolff D, Vagt M, Griem W: Studies on epidemiology and pathogenicity of porcine cirovirus.

    Archives of Virology 1986, 91:271-276. PubMed Abstract | Publisher Full Text OpenURL

  8. Allan GM, McNeilly F, Kennedy S, Daft B, Clarke EG, Ellis JA, Haines DM, Meehan BM, Adair BM: Isolation of porcine circovirus-like viruses from pigs with a wasting disease in the USA and Europe.

    Journal of Veterinary Diagnostic Investigation 1998, 10:3-10. PubMed Abstract | Publisher Full Text OpenURL

  9. Ellis J, Hassard L, Clark E, Harding J, Allan G, Willson P, Strokappe J, Martin K, McNeilly F, Meehan B, Todd D, Haines D: Isolation of circovirus from lessions of pigs with postweaning multisystemic wasting syndrome.

    The Canadian Veterinary Journal 1998, 39:44-51. OpenURL

  10. Fenaux M, Halbur PG, Haqshenas G, Royer R, Thomas P, Nawagitgul P, Gill M, Toth TE, Meng XJ: Cloned genomic DNA of type 2 porcine cirovirus is infectious when injected directly into the liver and lymph nodes of pigs: charaterization of clinical disease, virus distribution, and pathologic lesions.

    The Journal of Virology 2001, 76:541-551. Publisher Full Text OpenURL

  11. Fenaux M, Opriessnig T, Halbur PG, Meng XJ: Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine cirovirus type 2(PCV2) and nonpathogenic PCV1 in weaning pigs.

    The Journal of Virology 2003, 77:11232-11243. Publisher Full Text OpenURL

  12. Mankertz A, Mankertz J, Wolf K, Buhk HJ: Identification of a protein essential for replication of porcine circovirus.

    Journal of General Virology 1998, 79:381-384. PubMed Abstract | Publisher Full Text OpenURL

  13. Nawagitgul P, Morozov I, Bolin SR, Harms PA, Sorden SD: Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein.

    Journal of General Virology 2000, 81:2281-2287. PubMed Abstract | Publisher Full Text OpenURL

  14. Liu J, Chen I, Kwang J: Characterization of a Previously Unidentified Viral Protein in Porcine Circovirus Type 2-Infected Cells and Its Role in Virus-Induced Apoptosis.

    The Journal of Virology 2005, 79:8262-8274. Publisher Full Text OpenURL

  15. Ellis J, Krakowka S, Lairmore M, Haines D, Bratanich A, Clark E, Allan G, Konoby C, Hassard L, Meehan B, Martin K, Harding J, Kennedy S, McNeilly F: Reproduction of lesions of post-weaning multisystemic wasting syndrome in gnotobiotic piglets.

    Journal of Veterinary Diagnostic Investigation 1999, 11:3-14. PubMed Abstract | Publisher Full Text OpenURL

  16. O'Connor B, Gauvreau H, West K, Bogdan J, Ayroud M, Clark EG, Konoby C, Allan G, Ellis JA: Multiple porcine circovirus 2-associated abortions and reproductive failure in a multisite swine production unit.

    The Canadian Veterinary Journal 2001, 42:159-163. OpenURL

  17. Illanes O, Lopez A, Miller L, McLearon J, Yason C, Wadowska D, Martinez J: Lesions associated with postweaning multisystemic wasting syndrome in pigs from Prince Edward Island, Canada.

    Journal of Veterinary Diagnostic Investigation 2000, 12:146-150. PubMed Abstract | Publisher Full Text OpenURL

  18. Choi C, Chae C, Clark EG: Porcine postweaning multisystemic wasting syndrome in Korean pig: detection of porcine circovirus 2 infection by immunohistochemistry and polymerase chain reaction.

    Journal of Veterinary Diagnostic Investigation 2000, 12:151-153. PubMed Abstract | Publisher Full Text OpenURL

  19. Nayar GP, Hame A, Lin L: Detection and characterization of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs.

    The Canadian Veterinary Journal 1997, 38:385-386. OpenURL

  20. Onuki A, Abe K, Togashi K, Kawashima K, Taneichi A, Tsunemitsu H: Detection of porcine circovirus from lesions of a pig with wasting disease in Japan.

    The Journal of Veterinary Medical Science 1999, 61:1119-1123. PubMed Abstract | Publisher Full Text OpenURL

  21. Sato K, Shibahara T, Ishikawa Y, Kondo H, Kubo M, Kadota K: Evidence of porcine circovirus infection in pigs with wasting disease syndrome from 1985 to 1999 in Hokkaido, Japan.

    The Journal of Veterinary Medical Science 2000, 62:627-633. PubMed Abstract | Publisher Full Text OpenURL

  22. Segalés J, Sitjar M, Domingo M, Dee S, Del Pozo M, Noval R, Sacristan C, De las Heras A, Ferro A, Latimer KS: First report of post-weaning multisystemic wasting syndrome in pigs in Spain.

    The Veterinary Record 1997, 141:600-601. PubMed Abstract OpenURL

  23. Wellenberg GJ, Pesch S, Berndsen FW, Steverink PJ, Hunneman W, Van der Vorst TJ, Peperkamp NH, Ohlinger VF, Schippers R, Van Oirschot JT, de Jong MF: Isolation and characterization of porcine circovirus type 2 from pigs showing signs of post-weaning multisystemic wasting syndrome in the Netherlands.

    Veterinary Quarterly 2000, 22:167-172. PubMed Abstract OpenURL

  24. Allan GM, McNeilly F, Meehan BM, Kennedy S, Mackie DP, Ellis JA, Clark EG, Espuna E, Saubi N, Riera P, Botner A, Charreyre CE: Isolation and charaterization of circoviruses from pigs with wasting syndromes in Spain, Denmark and Northern Ireland.

    Veterinary Microbiology 1999, 66:115-123. PubMed Abstract | Publisher Full Text OpenURL

  25. Allan GM, Kennedy S, McNeilly F, Foster JC, Ellis JA, Krakowka SJ, Meehan BM, Adair BM: Experimental reproduction of wasting disease and death by coinfection of pigs with porcine cirocirus and porcine parvovirus.

    Journal of Comparative Pathology 1999, 121:1-11. PubMed Abstract | Publisher Full Text OpenURL

  26. Walker IW, Konoby CA, Jewhurst VA, McNair I, McNeilly F, Meehan BM, Cottrell TS, Ellis JA, Allan GM: Development and application of a competitive enzyme-linked immunosorbent assay for the detection of serum antibodies to porcine circovirus type 2.

    Journal of Veterinary Diagnostic Investigation 2000, 12:400-405. PubMed Abstract | Publisher Full Text OpenURL

  27. Blanchard P, Mahé D, Cariolet R, Truong C, Le Dimna M, Arnauld C, Rose N, Eveno E, Albina E, Madec F, Jestin A: An ORF2 protein-based ELISA for porcine circovirus type 2 antibodies in post-weaning multisystemic wasting syndrome.

    Veterinary Microbiology 2003, 66:183-194. Publisher Full Text OpenURL

  28. Liu C, Ihara T, Nunoya T, Ueda S: Development of an ELISA based on the baculovirus-expressed capsid protein of porcine circovirus type 2 as antigen.

    The Journal of Veterinary Medical Science 2004, 66:237-242. PubMed Abstract | Publisher Full Text OpenURL

  29. Mahe D, Blanchard P, Truong C, Arnauld C, Le Cann P, Cariolet R, Madec F, Albina E, Jestin A: Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes.

    Journal of General Virology 2000, 81:1815-1824. PubMed Abstract | Publisher Full Text OpenURL

  30. Truong C, Mahe D, Blanchard P, Le Dimna M, Madec F, Jestin A, Albina E: Indentification of an immunorelevant ORF2 epitope from porcine circovirus type 2 as a serological marker for experimental and natural infection.

    Archives of Virology 2001, 146:1197-1211. PubMed Abstract | Publisher Full Text OpenURL

  31. Liu Q, Willson P, Attoh-Poku S, Babiuk LA: Bacterial expression of an immunologically reactive PCV2 ORF2 Fusion Protein.

    Protein Expression and Purification 2001, 21:115-120. PubMed Abstract | Publisher Full Text OpenURL